Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Meningococcal polysaccharide vaccine |
Is a |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
|
Administration of first dose of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of second dose of meningitis C vaccine |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of third dose of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of single dose of meningitis C vaccine |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Meningococcal C conjugate vaccine injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Meningococcal C conjugate vaccine powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Meningococcal C conjugate vaccine injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Meningococcal C conjugate vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of Meningococcus vaccine |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Adverse reaction to component of vaccine product containing Neisseria meningitidis antigen (disorder) |
Causative agent (attribute) |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Meningitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
|
Meningitis ACW & Y vaccination |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Meningococcal group C vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Meningococcal A+C vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Meningococcal groups A+C+W135+Y vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Haemophilus influenzae type b + Meningococcal group C vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
2 |
Meningococcus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Meningococcal polysaccharide A, C, W135 and Y vaccine injection 0.5ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
|
Meningococcal polysaccharide A and C vaccine injection 0.5ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
|
Meningitis vaccine ac injection 1 Dose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
|
Administration of Haemophilus influenzae type b and meningitis C vaccine |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
2 |
Administration of Meningococcus vaccine |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of single dose of meningitis C vaccine |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of second dose of meningitis C vaccine |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Meningitis ACW & Y vaccination |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of first dose of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of third dose of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of Haemophilus influenzae type b and meningitis C vaccine |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
2 |
Administration of single dose of meningitis C vaccine |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of third dose of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Meningitis ACW & Y vaccination |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of second dose of meningitis C vaccine |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of first dose of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of Meningococcus vaccine |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Administration of booster dose of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
3 |
Administration of second dose of vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (procedure) |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
5 |
Administration of first dose of Haemophilus influenzae type b and meningitis C vaccine |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
5 |
Administration of meningitis C vaccine |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
3 |
Administration of meningitis B vaccine |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
3 |
Administration of second dose of vaccine product containing only Neisseria meningitidis serogroup B antigen (procedure) |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
3 |
Administration of booster dose of vaccine product containing only Neisseria meningitidis serogroup B antigen (procedure) |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
3 |
Meningococcus group B vaccine |
Is a |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
|
Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y capsular oligosaccharide conjugated antigens (procedure) |
Direct substance |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
1 |
Meningococcus group A vaccine |
Is a |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
|
Meningococcus group C vaccine |
Is a |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
|
Meningococcus group Y vaccine |
Is a |
False |
Meningococcus vaccine |
Inferred relationship |
Some |
|